Exelon (NASDAQ:EXC) Receives Overweight Rating from Morgan Stanley
Morgan Stanley reiterated their overweight rating on shares of Exelon (NASDAQ:EXC – Free Report) in a research report sent to investors on Friday morning, Benzinga reports. The brokerage currently has a $47.00 price target on the stock. A number of other research analysts have also commented on EXC. The Goldman Sachs Group assumed coverage on […]